Clinical Trial Update: An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung Cancer [EARLY_Phase 1]

View source ↗

Summary

An exploratory Phase 1 trial assessing the efficacy and safety of Iruplinalkib tablets in patients with ROS1-positive non-small cell lung cancer. The study, spo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iruplinalkib (iruplinalkib)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Non-Small Cell Lung Cancer | EARLY_Phase 1 | Status: RECRUITING